Santen Pharmaceutical Co., Ltd. (TYO: 4536)
Japan
· Delayed Price · Currency is JPY
1,850.50
-1.00 (-0.05%)
Oct 11, 2024, 3:15 PM JST
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 74.77B JPY in the quarter ending June 30, 2024, with 3.29% growth. This brings the company's revenue in the last twelve months to 304.35B, up 6.45% year-over-year. In the fiscal year ending March 31, 2024, Santen Pharmaceutical had annual revenue of 301.97B with 8.22% growth.
Revenue (ttm)
304.35B
Revenue Growth
+6.45%
P/S Ratio
2.21
Revenue / Employee
81.29M
Employees
3,744
Market Cap
645.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
Mar 31, 2020 | 241.56B | 7.53B | 3.22% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSanten Pharmaceutical News
- 2 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha